Shopping Cart
- Remove All
- Your shopping cart is currently empty
PSMA-D5 exhibits a binding affinity for PSMA with a Ki of 0.21 nM and becomes useful for PSMA tracing following radiolabeling. When marked with [68Ga], PSMA-D5 contains a DOTA chelator, facilitating the convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. Additionally, [68Ga]-labeled PSMA-D5 demonstrates exceptional pharmacokinetic properties and significant tumor uptake in 22Rv1 tumors. This compound can be employed in the synthesis and research of radiolabeled conjugates (RDC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | PSMA-D5 exhibits a binding affinity for PSMA with a Ki of 0.21 nM and becomes useful for PSMA tracing following radiolabeling. When marked with [68Ga], PSMA-D5 contains a DOTA chelator, facilitating the convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. Additionally, [68Ga]-labeled PSMA-D5 demonstrates exceptional pharmacokinetic properties and significant tumor uptake in 22Rv1 tumors. This compound can be employed in the synthesis and research of radiolabeled conjugates (RDC). |
In vitro | PSMA-D5 ([68 Ga] labeled) demonstrates excellent uptake performance in PSMA-positive 22Rv1 cells, with an uptake value of 1.68. |
In vivo | PSMA-D5 ([68 Ga] labeled), administered at approximately 3.7 MBq via intravenous injection, exhibits a high tumor uptake in 22Rv1 tumors (SUV max = 3.51). Compared to PSMA-11 ([68 Ga] labeled), it demonstrates improved visualization of smaller lesions, with T/M values of 32.01 and 26.8, respectively. |
Molecular Weight | 1317.31 |
Formula | C57H80N12O24 |
Cas No. | 3056440-83-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.